Goldman Sachs
BNTX icon

Goldman Sachs’s BioNTech BNTX Stock Holding History

Goldman Sachs’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,100
Closed -$4.96M – 6498
2025
Q4 		$4.96M Hold
52,100
– – ﹤0.01% 3754
2025
Q3 		$5.14M Hold
52,100
– – ﹤0.01% 3621
2025
Q2 		$5.55M Hold
52,100
– – ﹤0.01% 3316
2025
Q1 		$4.74M Hold
52,100
– – ﹤0.01% 3408
2024
Q4 		$5.94M Hold
52,100
– – ﹤0.01% 3284
2024
Q3 		$6.19M Buy
52,100
+35,200
+208% +$3.24M ﹤0.01% 3160
2024
Q2 		$1.36M Buy
16,900
+5,100
+43% +$466K ﹤0.01% 4240
2024
Q1 		$1.09M Buy
+11,800
New +$1.13M ﹤0.01% 4287
2023
Q4 		– Sell
-15,400
Closed -$1.67M – 5633
2023
Q3 		$1.67M Buy
+15,400
New +$1.7M ﹤0.01% 3906
2023
Q1 		– Sell
-112,300
Closed -$16.9M – 5929
2022
Q4 		$16.9M Buy
112,300
+44,600
+66% +$6.86M ﹤0.01% 2112
2022
Q3 		$9.13M Buy
67,700
+37,700
+126% +$5.76M ﹤0.01% 2595
2022
Q2 		$4.47M Sell
30,000
-44,800
-60% -$6.84M ﹤0.01% 3239
2022
Q1 		$12.8M Sell
74,800
-156,200
-68% -$26.2M ﹤0.01% 2449
2021
Q4 		$59.6M Buy
231,000
+111,000
+93% +$30.4M 0.01% 1205
2021
Q3 		$32.8M Buy
120,000
+30,500
+34% +$9.69M 0.01% 1622
2021
Q2 		$20M Buy
89,500
+39,500
+79% +$7.45M ﹤0.01% 2046
2021
Q1 		$5.46M Buy
+50,000
New +$5.31M ﹤0.01% 3059

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Goldman Sachs's BNTX Position: Q2 2026 in Review

Goldman Sachs increased its BioNTech (BNTX) stake by 509% in Q2 2026, buying an estimated $46.4M and bringing the position to 589,903 shares worth $54.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Goldman Sachs first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $84.7M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Goldman Sachs held 589,903 shares of BioNTech worth $54.9M as of Q2 2026.
  • Goldman Sachs bought 493,074 BioNTech shares in Q2 2026, an estimated $46.4M.
  • BioNTech made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1721 holding.
  • Goldman Sachs first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Goldman Sachs's BioNTech position peaked at $84.7M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.